Cetuximab Plus Cisplatin, Irinotecan and Thoracic Radiotherapy (TRT) for Locally Advanced (Non-Metastatic), Clinically Unresectable Esophageal Cancer: A Phase II Trial With Molecular Correlates.
Latest Information Update: 18 Sep 2021
At a glance
- Drugs Cetuximab; Cisplatin; Irinotecan
- Indications Oesophageal cancer
- Focus Therapeutic Use
- 18 Nov 2015 Biomarkers information updated
- 22 Aug 2012 Actual end date (1 May 2012) added as reported by ClinicalTrials.gov.
- 01 May 2012 Status changed from active, no longer recruiting to discontinued as reported by ClinicalTrials.gov.